BioLife Solutions, Inc. Shareholders' Equity
BioLife Solutions, Inc. (BLFS) had Shareholders' Equity of $420.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $420.00M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $372.23M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $371.89M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $353.74M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $420.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $372.23M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $371.89M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $353.74M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $347.15M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $352.62M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $348.91M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $325.46M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $321.44M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $333.40M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $337.66M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $332.02M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $352.13M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $358.11M 10-Q · filed 2024-08-09 | |
| 2022-12-31 | $364.19M 10-K · filed 2026-02-26 | |
| 2022-09-30 | $405.12M 10-Q · filed 2023-11-09 | $408.25M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $409.54M 10-Q · filed 2023-11-09 | $412.31M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $476.07M 10-Q · filed 2023-08-09 | $478.52M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $478.05M 10-K · filed 2025-03-03 | $480.14M 10-K · filed 2022-03-31 |
| 2021-09-30 | $489.26M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $452.28M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $208.78M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $204.43M 10-K · filed 2024-02-29 | $205.25M 10-K · filed 2021-03-31 |
| 2020-09-30 | $186.85M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $105.84M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $67.71M 10-Q · filed 2021-08-16 | |
| 2019-12-31 | $43.32M 10-K · filed 2023-03-31 | $43.45M 10-K · filed 2020-05-15 |
| 2019-09-30 | $35.19M 10-Q · filed 2020-11-09 | $76.96M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.07M 10-Q · filed 2020-11-09 | $46.27M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$3.74M 10-Q · filed 2020-08-10 | $44.37M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $14.63M 10-K · filed 2022-03-31 | $43.15M 10-K · filed 2019-03-15 |
| 2018-09-30 | -$6.50M 10-K · filed 2020-05-15 | $43.93M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$12.94M 10-K · filed 2020-05-15 | $19.66M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$4.25M 10-K · filed 2020-05-15 | $10.47M 10-Q · filed 2018-05-11 |
| 2018-01-01 | -$9.53M 10-K · filed 2020-05-15 | |
| 2017-12-31 | -$9.53M 10-K · filed 2020-05-15 | $10.09M 10-Q · filed 2018-05-11 |
| 2016-12-31 | $3.17M 10-K · filed 2019-03-15 | $3.17M 10-K · filed 2017-03-15 |
| 2016-09-30 | $6.16M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $6.82M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $7.44M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $8.51M 10-K · filed 2017-03-15 | $9.86M 10-K · filed 2016-02-25 |
| 2015-09-30 | $9.15M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $10.02M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $10.84M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $13.94M 10-K · filed 2016-02-25 | $11.80M 10-K · filed 2015-03-12 |
| 2014-09-30 | $12.67M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $13.40M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $14.08M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$13.27M 10-K · filed 2016-02-25 | |
| 2013-09-30 | -$12.86M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$12.66M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | -$12.40M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | -$12.49M 10-K · filed 2014-02-12 | |
| 2012-09-30 | -$12.04M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$11.74M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$11.43M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | -$11.18M 10-K · filed 2014-02-12 | |
| 2011-09-30 | -$10.82M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$10.48M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | -$9.55M 10-K · filed 2013-03-29 | |
| 2009-12-31 | -$7.83M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |